Hangzhou AGS Medtech Co (SHSE:688581) Total Current Liabilities: ¥119.4 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688581 Hangzhou AGS Medtech Co Ltd SHSE:688581
89 GF Score
Price ¥51.85
GF Value ¥75.76
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Hangzhou AGS Medtech Co Total Current Liabilities?

Hangzhou AGS Medtech Co SHSE:688581 -6.91% 89 Total Current Liabilities is ¥119.4 Mil as of Mar. 2026. GuruFocus rates SHSE:688581 with a GF Score™ of 89/100 and a GF Value™ of ¥75.76 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Hangzhou AGS Medtech Co's total current liabilities for the quarter that ended in Mar. 2026 was ¥119.4

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Hangzhou AGS Medtech Co Total Current Liabilities Related Terms

Hangzhou AGS Medtech Co Total Current Liabilities Historical Data

* Premium members only.

The historical data trend for Hangzhou AGS Medtech Co's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hangzhou AGS Medtech Co Total Current Liabilities Chart

Hangzhou AGS Medtech Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Current Liabilities
Get a 7-Day Free Trial Premium Member Only 0.00 91.03 120.74 141.99 151.90

Hangzhou AGS Medtech Co Quarterly Data
Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 92.45 209.60 99.31 151.90 119.39
SHSE:688581
89GF Score
Hangzhou AGS Medtech Co Ltd SHSE:688581
Total Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hangzhou AGS Medtech Co Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Hangzhou AGS Medtech Co's Total Current Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=101.644+36.411
+Other Current Liabilities+Current Deferred Liabilities
=13.845+0
=151.9

Hangzhou AGS Medtech Co's Total Current Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=79.024+31.359
+Other Current Liabilities+Current Deferred Liabilities
=9.004+0
=119.4

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

What does a Total Current Liabilities of ¥119.4 Mil mean?
Hangzhou AGS Medtech Co (SHSE:688581) has a Total Current Liabilities of ¥119.4 Mil as of Mar. 2026. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for Hangzhou AGS Medtech Co and its competitors.
Is Hangzhou AGS Medtech Co's Total Current Liabilities too high?
Hangzhou AGS Medtech Co's current Total Current Liabilities is ¥119.4 Mil. Overall, Hangzhou AGS Medtech Co has a GF Score™ of 89/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hangzhou AGS Medtech Co's Total Current Liabilities compare to ABT and SYK?
Hangzhou AGS Medtech Co's Total Current Liabilities of ¥119.4 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Liabilities for a Medical Devices & Instruments company?
A good Total Current Liabilities depends on the Medical Devices & Instruments industry context. However, Total Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Liabilities mean?
A high Total Current Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for Hangzhou AGS Medtech Co and its competitors. Hangzhou AGS Medtech Co's current Total Current Liabilities is ¥119.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hangzhou AGS Medtech Co stock overvalued right now?
Based on GuruFocus' analysis, Hangzhou AGS Medtech Co (SHSE:688581) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥75.76, compared to a current price of ¥51.85 — trading 31.6% below its estimated fair value. The current Total Current Liabilities is ¥119.4 Mil. Hangzhou AGS Medtech Co's overall GF Score™ is 89/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Liabilities calculated?
Total Current Liabilities is calculated from a company's financial statements. For Hangzhou AGS Medtech Co (SHSE:688581), the current Total Current Liabilities is ¥119.4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hangzhou AGS Medtech Co (SHSE:688581) Overvalued in 2026?

Based on GuruFocus' analysis, Hangzhou AGS Medtech Co stock appears to be undervalued. The current stock price of ¥51.85 is trading 31.6% below its estimated GF Value™ of ¥75.76. GuruFocus considers Hangzhou AGS Medtech Co to be Significantly Undervalued.

Key valuation signals for SHSE:688581:

  • Total Current Liabilities: ¥119.4 Mil
  • GF Value™: ¥75.76 vs. price of ¥51.85 (31.6% below fair value)
  • GF Score™: 89/100 with 4 warning signs

No single metric tells the full story. See the SHSE:688581 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hangzhou AGS Medtech Co Business Description

Address No. 389 Xingzhong Road, Linping District, Zhejiang Province, Hangzhou, CHN, 311199
Hangzhou AGS Medtech Co Ltd is engaged in Research & Development, production, and sales of endoscopic minimally invasive diagnosis and treatment devices. The company upholds the core values of create, insist, share, and provide patients and clinicians with safer and more efficient minimally invasive endoscopic devices, helping patients reduce pain and medical costs.
89GF Score

Get the complete analysis for SHSE:688581

Total Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥51.85
Price
¥75.76
GF Value